公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1993 | Test Dose Guided Rapid IV Suramine Infusions with Weekly IV Maintenance Doses | Arzoomanian, R.; Rago, R.; Cheng, Ann-Lii; Tombes, M. B.; Alberti, D.; Tusch, K.; Mutch, R.; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
2014 | The impact of diabetes mellitus on early cervical cancer in Asia: A population-based cohort study | Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu Yun; Hsu, Chiun; Chang, Wen-Fang; Chang, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 鄭安理 | J. Clin. Oncol. | | | |
2015 | Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model | Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
1994 | Use of Retinoic Acids in the Treatment of Peripheral T-Cell Lymphoma:a Pilot Study | 鄭安理 | Journal of Clinical Oncology | | | |
2013 | Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
1994 | Weekly 24-Hour Infusion with High-Dose 5 Fluorouracil Plus Leucovorin (HDFL) in Metastatic Colorectal Carcinoma | Cheng, Ann-Lii; Lin, M. T.; Wang, C. Y.; Wang, C. H.; Chen, Yee-Chun; Yeh, K. H.; 鄭安理 | Annual Meeting of Chinese Oncology Society | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
1987 | 以異體骨髓移植治療白血病之成果初報 | 陳耀昌; 王秋華; 林東燦; 雷德; 鄭安理; 劉滄梧; 蔡偉; 田蕙芬(Tien, Hwei-Fang); 劉美瑾; 褚文銘; 李麗娜; 蘇益仁(Su, Ih-Jen); 謝榮峰(Hsieh, Rong-Phong); 沈銘鏡(Shen, Ming-Ching); 劉禎輝(Hsieh | o-Sin | | | |
2008 | 內科系醫學(二)學門規劃研究推動計畫 | 鄭安理 | | | | |
2007 | 內科系醫學(二)學門規劃研究推動計畫 | 鄭安理 | | | | |
2005 | 原發性中樞神經系統淋巴瘤之研究 | 林璟宏; Lin, Ching-Hung | | | | |
1998 | 可溶性FAS接受體(SFAS)與胃癌之「嚴重度」與「化學治療反應性」相關性之研究 | 鄭安理 | | | | |
1999 | 基因合成之人類顆粒性白血球群落刺激因子 | 朱蓁蓁; 鄭安理; 林慧玲; 陳瑞龍 | Formosan Journal of Medicine | | | |
2011 | 急速增加的台灣年輕女性乳癌:臨床病理及腫瘤生物學研究 | 林璟宏; Lin, Ching-Hung | | | | |
1994 | 惡性淋巴瘤之治療學與相關腫瘤生物學之研究--著重於T細胞與B細胞淋巴瘤之比較 | 鄭安理 | | | | |
1993 | 惡性淋巴瘤之維生素A 酸受體基因轉位,表現及自我調節之研究 | 鄭安理 | | | | |
2008 | 探討上皮細胞癌與淋巴癌之間對mTOR抑制劑藥物敏感性的差異性表現之作用機轉 (新制多年期第1年) | 鄭安理 | | | | |
2006 | 泌尿上皮細胞癌全身性化學治療之研究 | 林家齊; Lin, Chia-Chi | | | | |
2008 | 癌末病情告知指引 | 胡文郁; 蔡甫昌; 鄭安理 | | | | |
2008 | 發炎與免疫反應在幽門桿菌非依存在性胃黏膜相關淋巴組織淋巴瘤轉型的角色-發炎與免疫反應在幽門桿菌非依存在性胃黏膜相關淋巴組織淋巴瘤轉型的角色(總計畫)(1/3) | 鄭安理 | | | | |